Package Leaflet: Information forthe user
ellaOne 30 mg tablet
Ulipristal acetate
Read this package leaflet carefully before starting to use this medicine, because it contains important information for you.
Follow exactly the administration instructions of the medicine contained in this package leaflet or as indicated by your doctor, pharmacist, or other healthcare professional.
Contents of the package leaflet:
ellaOne is an emergency contraceptive
ellaOne is a contraceptive intended to prevent pregnancy after unprotected sex or when a contraceptive method has failed. For example:
You should take the tablet as soon as possible after having unprotected sex, and no later than 5 days (120 hours) after.
This is because it is more effective the sooner you take it after having unprotected sex.
This medicine is suitable for any woman of childbearing age, including adolescents.
You can take the tablet at any time during your menstrual cycle.
ellaOne does not work if you are already pregnant
If you have a delayed period, you may be pregnant. If your period is delayed or you have symptoms of pregnancy (breast tenderness, morning sickness), you should consult a doctor or other healthcare professional before taking the tablet.
If you have unprotected sex after taking the tablet, it will not prevent you from becoming pregnant.
Unprotected sex can lead to pregnancy at any time during your menstrual cycle.
ellaOne should not be used as a regular contraceptive method
If you do not have a regular contraceptive method, talk to your doctor or other healthcare professional to help you choose the most suitable one for you.
How ellaOne works
ellaOne contains the active substance ulipristal acetate, which works by modifying the activity of the natural hormone progesterone necessary for ovulation to occur. As a result, this medicine works by delaying ovulation. Emergency contraception is not effective in all cases. Out of 100 women taking this medicine, about two will become pregnant.
This medicine is a contraceptive used to prevent pregnancy from occurring. If you are already pregnant, it will not interrupt an existing pregnancy.
Emergency contraceptives do not protect against sexually transmitted infections.
Only the use of a condom can protect you from sexually transmitted infections. This medicine will not protect you from HIV or any other sexually transmitted disease (e.g., chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, or syphilis). Consult a healthcare professional if you are concerned.
You will find more information about contraception at the end of this package leaflet.
Do not take ellaOne
Warnings and precautions
Consult your doctor, pharmacist, or other healthcare professional before starting to take this medicine
In all women, emergency contraception should be taken as soon as possible after having unprotected sex. There is some evidence that this medicine may be less effective with increasing body weight or body mass index (BMI), but these data were limited and not conclusive. Therefore, ellaOne is recommended for all women, regardless of their weight or BMI.
You are advised to consult a healthcare professional if you are concerned about any issues related to emergency contraception.
If you become pregnant despite taking the tablet, it is important that you consult your doctor. See the section "Pregnancy, breastfeeding, and fertility" for more information.
Using ellaOne with other contraceptives
This medicine may temporarily reduce the effectiveness of your regular hormonal contraceptives, such as the pill or patch. If you are currently using hormonal contraceptives, continue to use them as usual after taking this medicine, but make sure to use a condom every time you have sex until your next period.
Do not take this medicine with another emergency contraceptive pill that contains levonorgestrel. Taking them together may reduce the effectiveness of this medicine.
Other medicines and ellaOne
Tell your doctor, pharmacist, or other healthcare professional if you are taking or have recently taken any other medicines, including those obtained without a prescription or herbal medicines.
Some medicines may prevent ellaOne from working effectively. If you have used any of the following medicines in the last 4 weeks, ellaOne may be less effective for you. Your doctor may prescribe a different type of emergency contraception (non-hormonal), i.e., a copper intrauterine device (IUD):
Consult your doctor or pharmacist before using ellaOne if you are using (or have recently used) any of these medicines.
Pregnancy, breastfeeding, and fertility
Pregnancy
Before taking this medicine, if your period is delayed, talk to your doctor, pharmacist, or other healthcare professional or have a pregnancy test to make sure you are not already pregnant (see section "Warnings and precautions").
This medicine is a contraceptive used to prevent pregnancy from occurring. If you are already pregnant, it will not interrupt an existing pregnancy.
If you become pregnant despite taking this medicine, there is no evidence that it will affect your pregnancy. However, it is important that you consult your doctor. As with any pregnancy, your doctor may want to check that the pregnancy is not ectopic. This is especially important if you have severe abdominal pain or bleeding or if you have had an ectopic pregnancy, tubal surgery, or a long-standing genital infection in the past.
If you become pregnant despite taking ellaOne, we encourage you to talk to your doctor to register your pregnancy in an official registry. You can also report the information yourself at www.hra-pregnancy-registry.com. Your information will be kept anonymous; no one will know that the information refers to you. By sharing this information, you can help other women understand the safety or risks of ellaOne during pregnancy in the future.
Breastfeeding
If you take this medicine while breastfeeding, do not breastfeed your baby for the week after taking this medicine. We recommend that, during this week, you use a breast pump to maintain milk production but discard the expressed milk. The effect on the baby of breastfeeding in the week after taking this medicine is unknown.
Fertility
This medicine does not affect your future fertility. If you have unprotected sex after taking the tablet, it will not prevent you from becoming pregnant. Therefore, it is important that you use condoms until your next period.
If you want to start using or continue using a conventional contraceptive method after using this medicine, you can do so, but you must also use condoms until your next period.
Driving and using machines
After taking this medicine, some women may experience dizziness, drowsiness, blurred vision, or loss of concentration (see section 4). If you experience these symptoms, do not drive or use machines.
ellaOne contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow exactly the administration instructions of this medicine contained in this package leaflet or as indicated by your doctor, pharmacist, or other healthcare professional. If you are unsure, consult your doctor or pharmacist again.
How to take the ellaOne tablet
If you vomit after taking ellaOne
If you vomit (throw up) within 3 hours of taking the tablet, take another tablet as soon as possible.
If you have unprotected sex again after taking ellaOne
If you have unprotected sex after taking the tablet, it will not prevent you from becoming pregnant. After taking the tablet and until your next period, you must use condoms every time you have sex.
If your next period is delayed after taking ellaOne
After taking the tablet, it is normal for your next period to be delayed by a few days. However, if your period is delayed by more than 7 days, is shorter or longer than usual, or if you experience symptoms such as abdominal pain, breast tenderness, vomiting, or nausea, you may be pregnant. You should have a pregnancy test immediately. If you are pregnant, it is important that you consult your doctor (see section "Pregnancy, breastfeeding, and fertility").
If you take more ellaOne than you should
No harmful effects have been reported with taking a higher dose of this medicine than recommended. However, consult your doctor, pharmacist, or other healthcare professional.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or other healthcare professional.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Some symptoms, such as breast tenderness and abdominal pain, vomiting, and nausea, are also possible signs of pregnancy. If your period does not arrive and you experience these symptoms after taking ellaOne, you should have a pregnancy test (see section 2 "Pregnancy, breastfeeding, and fertility").
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1,000 people):
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or other healthcare professional, even if they are not listed in this package leaflet. You can also report them directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and blister after "EXP". The expiry date is the last day of the month stated.
Store below 25°C. Store in the original package to protect from moisture. Store the blister in the outer carton to protect from light.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of ellaOne
Appearance of the Product and Package Contents of ellaOne
ellaOne is a curved, round tablet, 9 mm in diameter, white to cream marbled in color, with «ella» engraved on both sides.
ellaOne is marketed in a box containing a blister pack with 1 tablet.
Marketing Authorization Holder
LABORATOIRE HRA PHARMA
200 avenue de Paris
92320 CHATILLON
France
Email: info-ella@hra-pharma.com
Manufacturer
Cenexi
17, rue de Pontoise
95520 Osny
France
Laboratorios León Farma S.A.
C/ La Vallina, s/n Pol. Ind. Navatejera
24008 Navatejera, León
Spain
Delpharm Lille S.A.S.
Parc d’activités Roubaix-Est
22, rue de Toufflers
CS 50070
59452 Lys-Lez-Lannoy
France
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Belgium Omega Pharma Belgium NV Tel: +32 (0)9 381 04 30 | Lithuania Orivas UAB Tel: +370 5 252 6570 |
MagnaPharm Bulgaria EAD. Tel: + 359 800 12 400 | Luxembourg Omega Pharma Belgium NV Tel: +32 (0)9 381 04 30 |
Czech Republic Akacia Group, s.r.o. Tel: + 420-(0)220 610 491 | Hungary Zentiva Pharma Kft. Tel: + 36 1 299 1058 |
Denmark Perrigo Sverige AB Tel: +46 8 59 00 29 00 | Malta Laboratoire HRA Pharma Tel: + 33-(0)1 40 33 11 30 |
Germany HRA Pharma Deutschland GmbH Tel: + 49-(0) 611 890777-0 | Netherlands Omega Pharma Nederland BV Tel: +31 (0) 10 2211007 |
Estonia Orivas OÜ Tel: +372 639 8845 | Norway Perrigo Sverige AB Tel: +46 8 59 00 29 00 |
Greece ΒΙΑΝΕΞ Α.Ε. Tel: + 30 210 8009111-120 | Austria HRA Pharma Deutschland GmbH Tel: + 49-(0) 611 890777-0 |
Spain HRA Pharma Iberia S.L. Tel: + 34-(0)902 107 428 | Poland MagnaPharm Poland Sp. z o. o. Tel: + 48 (22) 570 27 00 |
France Laboratoire Perrigo France Tel: + 33-(0) 1 55 48 18 00 | Portugal Perrigo Portugal Lda. Tel: +351 214 167 610 |
Croatia Arenda d.o.o. Tel: + 385-(0)1 644 44 80 | Romania MagnaPharm Marketing & Sales Romania S.R.L. Tel: + 40 372 502 221 |
Ireland Laboratoire HRA Pharma Tel: + 33-(0)1 40 33 11 30 | Slovenia Dr. Gorkic d.o.o. Tel: + 386-(0)1 7590 251 |
Iceland Laboratoire HRA Pharma Tel: + 33-(0)1 40 33 11 30 | Slovakia Liek, s.r.o. Tel: + 421-(0)905 667 410 |
Italy Perrigo Italia S.r.l Tel: + 39 06 90250333 | Finland Perrigo Sverige AB Tel: +46 8 59 00 29 00 |
Cyprus ΒΙΑΝΕΞ Α.Ε. Tel: + 30 210 8009111-120 | Sweden Perrigo Sverige AB Tel: +46 8 59 00 29 00 |
Latvia Orivas SIA Tel: +371 676 124 01 | United Kingdom (Northern Ireland) Laboratoire HRA Pharma Tel: + 33-(0)1 40 33 11 30 |
Date of the Last Revision of this Leaflet:
Detailed information on this medication is available on the European Medicines Agency website: http://www.ema.europa.eu/.
USEFUL INFORMATION ABOUT CONTRACEPTION
MORE ABOUT EMERGENCY CONTRACEPTION
The sooner you take emergency contraception, the more likely you are to avoid pregnancy. Emergency contraception does not affect your fertility.
Emergency contraception may delay ovulation within a given menstrual cycle, but it will not prevent you from getting pregnant if you have unprotected sex again. After taking emergency contraception and until your next period, you should use condoms every time you have sex.
MORE ABOUT REGULAR CONTRACEPTION
If you have taken emergency contraception and are not using a regular contraceptive method (or do not have a contraceptive method that suits you), consult your doctor or a family planning clinic. There are many different types of contraceptives, and you should be able to find one that is suitable for you.
Examples of regular contraceptive methods include:
Daily Methods Contraceptive pill | |
Weekly or Monthly Methods | |
Contraceptive patch | Vaginal ring |
Long-term Methods | |
Contraceptive implant | IUD (intrauterine device) |